Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Pigmentation

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PARP1 as a biomarker for differentiating melanoma from benign melanocytic lesions.

The Journal of investigative dermatology·2026

Same author

The role of KDM5B in creating synthetic vulnerabilities in combination with radiotherapy in melanoma cells.

Cell communication and signaling : CCS·2026

Same author

Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study.

European journal of cancer (Oxford, England : 1990)·2026

Same author

Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma.

The British journal of dermatology·2026

Same author

Comparing dermatologists' and artificial intelligence heat maps in dermoscopic image analysis via eye tracking.

Journal of the American Academy of Dermatology·2026

Same author

Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients.

Frontiers in immunology·2026

Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026

Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026

Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 21, 2026

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Melanoma.

Dirk Schadendorf^1,2, David E Fisher³, Claus Garbe^2,4

¹Department of Dermatology, University Duisburg-Essen, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.

Nature Reviews. Disease Primers

|May 19, 2016

Summary

This summary is machine-generated.

Melanoma incidence is rising, with sun exposure as a key risk factor. Advances in understanding genetic mutations and developing targeted therapies like BRAF inhibitors and PD1-specific antibodies are significantly improving patient prognosis and quality of life.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Related Experiment Videos

Last Updated: Mar 21, 2026

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Area of Science:

Oncology
Dermatology
Genetics

Background:

Melanoma is a prevalent and increasing cancer in Western countries.
Sun exposure is the primary risk factor, but genetic alterations also play a crucial role.
Early detection campaigns have reduced mortality rates.

Purpose of the Study:

To summarize current understanding of melanoma, covering mechanistic insights and clinical progress.
To highlight the significance of genetic mutations in melanoma development and treatment.
To review recent therapeutic advancements and their impact on patient outcomes.

Main Methods:

Review of current scientific literature on melanoma.
Analysis of genetic alterations associated with different melanoma subtypes.
Evaluation of novel therapeutic strategies, including targeted therapies and immunotherapies.

Main Results:

Key genetic mutations identified include BRAF, NRAS, KIT, GNAQ, GNA11, and alterations in the PI3K-AKT-PTEN and immune checkpoint pathways.
Programmed cell death protein 1 (PD1) pathway inhibitors (e.g., nivolumab, pembrolizumab) show promise.
BRAF and MEK inhibitors have significantly improved outcomes for advanced-stage metastatic melanoma.

Conclusions:

Understanding melanoma's genetic landscape is critical for effective treatment.
Novel therapies are transforming melanoma prognosis, improving long-term benefits and quality of life.
Continued research into melanoma mechanisms and treatments is essential.